Suchergebnisse - "Simpson, Iain"

PubPharm (249)

81

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2020

von MLYNARSKI SCOTT NATHAN | GREBE TYLER | KAWATKAR SAMEER | +2

82

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2020

von MLYNARSKI SCOTT NATHAN | GREBE TYLER | KAWATKAR SAMEER | +2

83

ARGINASE INHIBITORS AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2020

von MLYNARSKI SCOTT NATHAN | GREBE TYLER | KAWATKAR SAMEER | +2

84

Therapeutic delivery : industry update covering November 2019

enthalten in: Therapeutic delivery | 2020

von Simpson, I.

85

enthalten in: Europäisches Patentamt | 2020

von ESPENSEN MAX | PATIENT LEE | EVANS DAVID | +2

86

Inhibidores de SSAO derivados de imidazo[4,5-c]piridina

enthalten in: Europäisches Patentamt | 2020

von PATIENT LEE | SIMPSON IAIN | SAVORY EDWARD

87

Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias : lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205

enthalten in: Atherosclerosis | 2020

von Task Force Members | ESC National Cardiac Societies | ESC Committee for Practice Guidelines (CPG) | +100

ErratumFor: Atherosclerosis. 2019 Nov;290:140-205. - PMID 31591002

88

2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

enthalten in: European heart journal | 2020

von Brugada, J. | Katritsis, D. | Arbelo, E. | +119

ErratumIn: Eur Heart J. 2020 Nov 21;41(44):4258. - PMID 31837137

89

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

enthalten in: European heart journal | 2020

von Konstantinides, S. | Meyer, G. | Becattini, C. | +121

CommentIn: Vasa. 2020 Jun;49(4):257-258. - PMID 32578520

90

Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias : Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205

enthalten in: Atherosclerosis | 2020

von Authors/Task Force Members | ESC National Cardiac Societies | ESC Committee for Practice Guidelines (CPG) | +100

ErratumFor: Atherosclerosis. 2019 Nov;290:140-205. - PMID 31591002